EUVIMEDEUVIMED entdecken
Crossref

Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer

Carrie Printz

CA: A Cancer Journal for Clinicians · 2026-03 · 76 (2)

DOI: 10.3322/caac.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 20.04.2026. Verfasst von Carrie Printz.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Printz, C. (2026). Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer. CA: A Cancer Journal for Clinicians, 76(2). https://doi.org/10.3322/caac.70077

Vancouver

Printz C. Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer. CA: A Cancer Journal for Clinicians. 2026;76(2). doi:10.3322/caac.70077

BibTeX
@article{Printz2026,
  author = {Printz, Carrie},
  title = {Adding carboplatin to sequential taxane–anthracycline neoadjuvant chemotherapy shows improved event‐free and overall survival benefits in premenopausal women with triple‐negative breast cancer},
  journal = {CA: A Cancer Journal for Clinicians},
  year = {2026},
  volume = {76},
  number = {2},
  doi = {10.3322/caac.70077}
}
Kostenlos starten →